Edition:
United States

Rhoen Klinikum AG (RHKG.DE)

RHKG.DE on Xetra

25.35EUR
24 Mar 2017
Change (% chg)

€0.01 (+0.04%)
Prev Close
€25.34
Open
€25.39
Day's High
€25.42
Day's Low
€25.21
Volume
79,319
Avg. Vol
152,846
52-wk High
€28.73
52-wk Low
€22.66

Latest Key Developments (Source: Significant Developments)

Rhoen Klinikum FY net consolidated profit was at EUR 58.6 mln
Friday, 24 Feb 2017 01:08am EST 

Rhoen Klinikum AG : FY corporate revenues stood at 1.18 billion euros ($1.25 billion) with earnings before interest, taxes, depreciation and amortisation (EBITDA) amounting to 156.9 million euros . FY EBITDA without these subsequent transaction effects amounted to 114.9 million euros . FY net consolidated profit was at 58.6 million euros . For current financial year 2017 expects regulatory legislation to place a burden on future business . For FY 2017 expects only modest organic growth and revenues of between 1.20 billion euros and 1.23 billion euros .EBITDA might be burdened in 2017 and be clearly lower in comparison with last year.  Full Article

Rhoen-Klinikum reduces size of management board
Thursday, 23 Feb 2017 06:22am EST 

Rhoen Klinikum AG : Reduces size of management board . To reduce size of management board from five to three members by revoking appointment of Martin Menger (operative business) and Jens-Peter Neumann (finance) to management board . Management board of company therefore consists of Stephan Holzinger (chairman), Martin Siebert (deputy chairman) and Bernd Griewing .In particular, Holzinger has also assumed responsibilities of CFO.  Full Article

Rhoen Klinikum: removal of management board members Martin Menger and Jens-Peter Neumann
Thursday, 16 Feb 2017 07:54am EST 

Rhoen Klinikum AG : Personnel committee of the supervisory board recommends reducing the management board by removing management board members Martin Menger and Jens-Peter Neumann .Rhoen klinikum - if supervisory board accepts this recommendation, management board of company will in future consist of Stephan Holzinger (chairman), Martin Siebert (deputy chairman) and Bernd Griewing.  Full Article

Rhoen Klinikum: value adjustment in connection with financial investment in MIT GmbH
Tuesday, 14 Feb 2017 09:17am EST 

Rhoen Klinikum AG : Value adjustment in connection with financial investment in mit gmbh in amount of approx. 35.5 million euros ($37.66 million) . Value adjustment results from operational delays in connection with initial operating phase of Marburg Ion Therapy Center .Resulting negative impact affects financial result and consolidated result 2016 by a corresponding amount.  Full Article

Rhoen Klinikum says plans to appoint Stephan Holzinger as new CEO
Thursday, 19 Jan 2017 12:20pm EST 

Rhoen Klinikum AG : dgap-adhoc: rhön-klinikum ag: decision making process of supervisory board of rhön- klinikum concerning reorganization of management board . Says in case resolution is passed, supervisory board would appoint Stephan Holzinger with effect as of 01 February 2017 as member of management board . Says together with his appointment to management board Stephan Holzinger would at same time become its chairman .Says Martin Siebert, who has been chairman so far, would become vice chairman of management board for personal reasons.  Full Article

Rhoen Klinikum: significant structural burdens on FY 2017 results
Thursday, 19 Jan 2017 06:04am EST 

Rhoen Klinikum AG : Management board expects since today significant structural burdens on results in a range of low to middle two digit millions for current financial year 2017 . Will adjust its regular financial forecast .Last year's financial results of company are positively affected by high one time effects.  Full Article

Rhoen Klinikum sees regulatory obstacles, confirms outlook
Friday, 4 Nov 2016 01:59am EDT 

Rhoen Klinikum AG : 9M revenues at euro 885.3 million . EBITDA in amount of euro 131.5 million includes dissolving provisions of euro 41 million . Outlook for 2016 remains unchanged: revenues between euro 1.17 billion and euro 1.20 . 2016 EBITDA seen between euro 155 million and euro 165 million . 615,629 patients treated in first 9 months . Regulatory obstacles will affect organic growth in 2016, placing burden of a lower increase in revenues of roughly 1% . .  Full Article

Rhoen Klinikum says H1 EBITDA up 23 pct at 103 mln eur
Thursday, 4 Aug 2016 01:05am EDT 

Rhoen Klinikum Ag : news: rhön-klinikum ag: interim report for the first six months of 2016:rhön-klinikum ag continues its strong growth - strategic focus on network medicine and digitalisation . Says 414,403 patients treated . Says ebitda in amount of euro 103.4 million includes dissolving provisions of euro 41 million . Says outlook for 2016 remains unchanged: revenues between euro 1.17 billion and euro 1.20 billion . Says ebitda between euro 155 million and euro 165 million . Says must expect a drop in revenues of roughly 1 % for current financial year arising, in particular, from discounts on additional volume which were agreed in 2013 .Says revenues stand at euro 590.6 million.  Full Article

B. Braun's stake in Rhoen-Klinikum rises to 20 pct
Wednesday, 25 May 2016 08:15am EDT 

Rhoen Klinikum AG :Says shareholder B. Braun's holding in company has risen to just over 20 percent versus 18.01 percent.  Full Article

B. Braun hasn't yet decided whether to buy more Rhoen shares
Wednesday, 25 May 2016 08:15am EDT 

Rhoen Klinikum AG : Shareholder b. Braun says holding in rhön-klinikum is assumed as a long-term strategic investment . Notifying persons have not completed yet their considerations to obtain further voting rights within the next twelve months .Notifying persons do not intend to change the capital structure of Rhoen-Klinikum.  Full Article

More From Around the Web

BRIEF-Asklepios owner hikes stake in Rhoen-Klinikum to more than 20 pct

* Says Asklepios owner Broermann's holding in Rhoen rises to 20.2 percent from 17.6 percent Source text for Eikon: Further company coverage: